Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$440,000 |
 |
Johnson & JohnsonJNJ |
-$120M |
 |
Mind Medicine (MindMed)MNMD |
-$86M |
 |
ModernaMRNA |
-$37.4B |
 |
AbbVieABBV |
-$792M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Looker Benjamin | Jan 20, 2026 | Sell | 1,689 | $2.882 | $4,900 |
| Koenig Sheldon L. | Dec 17, 2025 | Sell | 48,244 | $3.673 | $180,000 |
| Halladay Benjamin | Dec 17, 2025 | Sell | 7,337 | $3.667 | $27,000 |
| Looker Benjamin | Dec 17, 2025 | Sell | 6,517 | $3.667 | $24,000 |
| Looker Benjamin | Oct 17, 2025 | Sell | 1,248 | $2.6245 | $3,300 |
| Halladay Benjamin | Sep 17, 2025 | Sell | 7,046 | $2.808 | $20,000 |
| Looker Benjamin | Sep 17, 2025 | Sell | 6,267 | $2.804 | $18,000 |
| Koenig Sheldon L. | Sep 17, 2025 | Sell | 28,427 | $2.788 | $79,000 |
| Looker Benjamin | Jul 17, 2025 | Sell | 1,304 | $1.127 | $1,500 |
| Halladay Benjamin | Jul 17, 2025 | Sell | 11 | $1.115 | $12 |
| Looker Benjamin | Jun 17, 2025 | Sell | 6,422 | $1.152 | $7,400 |
| Koenig Sheldon L. | Jun 17, 2025 | Sell | 30,474 | $1.109 | $34,000 |
| Halladay Benjamin | Jun 17, 2025 | Sell | 7,229 | $1.152 | $8,300 |
| Warren Eric | Apr 17, 2025 | Sell | 108 | $0.978 | $110 |
| Halladay Benjamin | Apr 17, 2025 | Sell | 8 | $0.964 | $8 |
| Warren Eric | Mar 18, 2025 | Sell | 2,433 | $1.487 | $3,600 |
| Halladay Benjamin | Mar 18, 2025 | Sell | 3,535 | $1.483 | $5,200 |
| Koenig Sheldon L. | Mar 18, 2025 | Sell | 13,047 | $1.504 | $20,000 |
| Warren Eric | Feb 19, 2025 | Sell | 239 | $1.868 | $450 |
| Halladay Benjamin | Feb 19, 2025 | Sell | 11 | $1.86 | $20 |
| Halladay Benjamin | Jan 17, 2025 | Sell | 9 | $2.265 | $20 |
| Warren Eric | Jan 17, 2025 | Sell | 123 | $2.26 | $280 |
| Halladay Benjamin | Dec 17, 2024 | Sell | 3,245 | $2.424 | $7,900 |
| Warren Eric | Dec 17, 2024 | Sell | 2,234 | $2.429 | $5,400 |
| Koenig Sheldon L. | Dec 17, 2024 | Sell | 12,447 | $2.466 | $31,000 |
| Warren Eric | Nov 19, 2024 | Sell | 197 | $2.165 | $430 |
| Warren Eric | Oct 17, 2024 | Sell | 107 | $2.119 | $230 |
| Koenig Sheldon L. | Sep 17, 2024 | Sell | 14,550 | $1.796 | $26,000 |
| Warren Eric | Sep 17, 2024 | Sell | 2,608 | $1.783 | $4,700 |
| Warren Eric | Aug 19, 2024 | Sell | 211 | $1.946 | $410 |
| Warren Eric | Jul 17, 2024 | Sell | 108 | $2.587 | $280 |
| Foody Joanne M. | Jul 17, 2024 | Sell | 917 | $2.599 | $2,400 |
| Foody Joanne M. | Jun 18, 2024 | Sell | 3,285 | $2.867 | $9,400 |
| Warren Eric | Jun 18, 2024 | Sell | 2,540 | $2.856 | $7,300 |
| Warren Eric | May 17, 2024 | Sell | 192 | $2.483 | $480 |
FAQ - Insider Transactions
The most recent insider transaction for Esperion Therapeutics was conducted by Looker Benjamin, who sold 1,689 shares on January 20, 2026 at a price of $2.88 per share.
Koenig Sheldon L. has sold the most ESPR stock in the last 2 years, with a total value of $370,000.
The total value of insider transactions for Esperion Therapeutics in the last 2 years is negative, amounting to -$530,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Esperion Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
